Evidence for Cytogenetic and Fluorescence In Situ Hybridization Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies

Overall survival (OS) has improved with increasing use of novel agents in multiple myeloma (MM). However, the disease course remains highly variable, and the heterogeneity largely reflects different genetic abnormalities. We studied the impact of the Mayo risk-stratification model of MM on patient o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kapoor, Prashant, Fonseca, Rafael, Rajkumar, S. Vincent, Sinha, Shirshendu, Gertz, Morie A., Stewart, A. Keith, Bergsagel, P. Leif, Lacy, Martha Q., Dingli, David D., Ketterling, Rhett P., Buadi, Francis, Kyle, Robert A., Witzig, Thomas E., Greipp, Philip R., Dispenzieri, Angela, Kumar, Shaji
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Mayo Foundation for Medical Education and Research 2010
Aiheet:
Brief Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2878257/
https://ncbi.nlm.nih.gov/pubmed/20511484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4065/mcp.2009.0677
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia